[HTML][HTML] Speaking in Alzheimer's disease, is that an early sign? Importance of changes in language abilities in Alzheimer's disease

…, I Hoffmann, V Vincze, J Kalman, M Pakaski - Frontiers in aging …, 2015 - frontiersin.org
It is known that Alzheimer’s disease (AD) influences the temporal characteristics of spontaneous
speech. These phonetical changes are present even in mild AD. Based on this, the …

P331 Lung function in obese school children in pancevo

SF Baumann, SS Baumann, S Pakaški, M Deanović - 2017 - adc.bmj.com
… Methods We performed the spirometric tests of lung function with Jeger’s spirometer ,,Vyntus …
Spirometric values between groups were compared by Student’s T-test. Relations of BMI …

Temporal speech parameters detect mild cognitive impairment in different languages: validation and comparison of the Speech-GAP Test® in English and Hungarian

…, I Kovács, V Vincze, M Pákáski - Current Alzheimer …, 2022 - ingentaconnect.com
… From this output, the 15 S-GAP parameters can be obtained … Based on this, Pearson’s
correlation values of the speech … of duration led to Pearson’s correlation values of 0.914 and 0.920…

Influence of high values of airpollutants on exacerbations of acute asthma attack in children from Pančevo in 2010/2011

S Baumann, S Prodanović, S Baumann… - Materia …, 2011 - scindeks.ceon.rs
It is known influence of airpollutants on worsening of asthma in children. The aim of this study
is to show how a typical airpollutants (soot, TSP, NO2, SO2, NH3, and benzene) affect on …

Assessing Alzheimer's disease from speech using the i-vector approach

…, L Tóth, I Hoffmann, J Kálmán, M Pákáski… - Speech and Computer …, 2019 - Springer
One of the world’s chronic neuro-degenerative diseases, Alzheimer’s Disease (AD), leads
its sufferers, among other symptoms, to suffer from speech difficulties. In particular, the …

Serum adipokine levels modified by donepezil treatment in Alzheimer's disease

M Pákáski, A Fehér, A Juhász, G Drótos… - Journal of …, 2014 - content.iospress.com
… Neurotransmitter enhancement therapy with acetylcholinesterase inhibitors (AChEIs) is a
clinically proven approach for patients with Alzheimer’s disease (AD). Donepezil is one of the …

Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease

M Pákáski, J Kálmán - Neurochemistry international, 2008 - Elsevier
… caused a redistribution of the AChE within the cells (Pakaski et al., 1998). The specific staining
… Further work will be required to address the exact mechanism(s) by which Aβ antibodies …

Proteomic analysis of cerebrospinal fluid in Alzheimer's disease: wanted dead or alive

…, M Sántha, E Ivitz, Z Janka, M Pákáski - Journal of …, 2015 - content.iospress.com
… Tau) according to the manufacturer’s instructions. Internationally accepted AD specific cutoff
… duplicated (Alzheimer’s disease 1A and 1B; control 1A and 1B, Alzheimer’s disease 2A and …

Identifying mild cognitive impairment and mild Alzheimer's disease based on spontaneous speech using ASR and linguistic features

G Gosztolya, V Vincze, L Tóth, M Pákáski… - Computer Speech & …, 2019 - Elsevier
Alzheimer’s disease (AD) is a neurodegenerative disorder that develops for years before
clinical manifestation, while mild cognitive impairment is clinically considered as a prodromal …

Connection of air pollution and acute asthma attack in children in Pancevo

S Baumann, S Pakaski, M Deanovic - 2019 - Eur Respiratory Soc
… In 145 days of exceeding EMLV aeroplutants, 2063 children visited the doctor, while in
220 days without exceeding EMLV, the doctor’s help was requested by 2018 children. This …